Breast Cancer Clinical Trial
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Summary
The purpose of this prospective, interventional, single-arm pilot study is to evaluate whether virtually delivered group-based physical activity is feasible for adolescent and young adult (AYA) cancer survivors. AYAs who were diagnosed with cancer and have completed cancer treatment will be recruited for this study. This study will enroll 20 participants in total and will last approximately 3 months.
Full Description
This is a single-arm, prospective, interventional pilot study.
Adolescent and young adult (AYA) survivors of cancer ages 18-39 (n=20) will engage in three months of virtually group physical activity (PA) delivered via BurnAlong, a wellness platform and online app.
Participants will be asked to engage in a BurnAlong workout session with a partner (friend/spouse/child/fellow study participant) a minimum of three times a week for 3 months.
Participants will also meet monthly with an exercise physiologist for a customized exercise session. Participants are allowed to engage in additional PA and non-PA sessions on BurnAlong as desired.
Participants will also be asked to engage in a private social network discussions around key topics of interest for AYA communities with a focus on post-traumatic growth and positive psychology with a minimum of 2 post engagements a week for 3 months.
Participants will complete surveys and physical assessments at baseline and at end of study.
Participants also participate in a 1 hr qualitative exit interview about their well-being, participation experiences, and experience with using the BurnAlong platform.
Eligibility Criteria
Inclusion Criteria:
Cancer (all types) diagnosis between the ages of 15-39
Between the ages of 18-39 during study participation
At least 3 months post-active treatment completion
Answers "no" to all questions on the Physical Activity Readiness Questionnaire
Not currently meeting physical activity guidelines per leisure-time physical activity participation questionnaire
Access to and ability to use a computer, tablet or phone device with internet access
Ability to understand and read English
Written informed consent obtained from subject and ability for subject to comply with the requirements of the study
Exclusion Criteria:
Hearing loss or vision impairment that would preclude the participant from accessing and using the app (use of hearing aids or visual aids is acceptable) based on self-report
Currently meeting physical activity guidelines (score of >23 on Godin-Shephard Leisure-Time Physical Activity Questionnaire)
Currently pregnant, based on self-report
Patients with active treatment planned within the next 3 months. (Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination.) Long-term hormonal/biologic treatments are acceptable except for AR-targeted therapies for prostate cancer. Participants with known metastatic disease, grade 3 or higher neuropathy, major surgery within 3 months of baseline visit, pregnancy of childbearing potential will be excluded.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Los Angeles California, 90048, United States More Info
Principal Investigator
Sub-Investigator
Sub-Investigator
Sub-Investigator
How clear is this clinincal trial information?